Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PTN Palatin Technologies Inc New

0.00 (0.0%)
Pre Market
Last Updated: 07:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Palatin Technologies Inc New PTN AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.36 07:00:00
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
12/04/202317:00EDGAR2Form S-1 - General form for registration of securities under..
12/01/202315:52EDGAR2Form 144 - Report of proposed sale of securities
11/14/202307:30PRNUSPalatin Reports First Quarter Fiscal Year 2024 Financial..
11/09/202307:30PRNUSPalatin to Report First Quarter Fiscal Year 2024 Results;..
10/24/202316:50PRNUSPalatin Announces Closing of $5 Million Registered Direct..
10/24/202316:05EDGAR2Form 8-K - Current report
10/24/202314:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/23/202307:30PRNUSPalatin Announces $5 Million Registered Direct Offering
10/19/202308:01EDGAR2Form 8-K - Current report
10/19/202307:30PRNUSPalatin Announces Preliminary Quarter Ended September 30,..
10/18/202307:30PRNUSPalatin Announces Positive Preclinical Data Showing..
10/16/202307:30PRNUSPalatin Presents Data at the United European..
10/13/202316:31EDGAR2Form 8-K - Current report
10/13/202316:15PRNUSPalatin Receives Notice of Non-Compliance from NYSE American
9/28/202308:02EDGAR2Form 8-K - Current report
9/28/202308:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
9/28/202307:30PRNUSPalatin Reports Fourth Quarter and Fiscal Year Ended 2023..
9/22/202316:00PRNUSPalatin to Report Fourth Quarter and Fiscal Year End 2023..
9/08/202308:00EDGAR2Form 8-K - Current report
9/07/202316:00PRNUSPalatin to Present at the H.C. Wainwright 25th Annual Global..
9/07/202308:49EDGAR2Form 8-K - Current report
9/07/202307:30PRNUSPalatin Completes Enrollment in Phase 3 MELODY-1 Study of..
8/16/202321:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/16/202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202308:15EDGAR2Form 8-K - Current report
8/10/202307:30PRNUSPalatin Initiates Clinical Program for Bremelanotide..
8/08/202308:00EDGAR2Form 8-K - Current report
8/08/202307:30PRNUSPalatin's Vyleesi® Licensee Fosun Pharma Reports First..
8/07/202308:00EDGAR2Form 8-K - Current report
8/07/202307:30PRNUSPalatin Announces Direct-to-Consumer Telehealth Partnership..
8/04/202308:00EDGAR2Form 8-K - Current report
8/04/202307:30PRNUSPalatin to Participate in Canaccord Genuity's 43rd Annual..
7/11/202308:25EDGAR2Form 8-K - Current report
7/11/202307:30PRNUSPalatin Announces Preliminary Fourth Quarter Fiscal 2023..
5/30/202307:30PRNUSPalatin Presents Preclinical Diabetic Nephropathy Data at..
5/16/202307:30PRNUSPalatin Reports Third Quarter Fiscal Year 2023 Financial..
5/11/202316:15PRNUSPalatin to Report Third Quarter Fiscal Year 2023 Results;..
5/09/202307:30PRNUSPalatin Presents PL8177 Ulcerative Colitis Data at Digestive..
5/08/202316:04PRNUSPalatin Invites Investors to Listen to Replay of the PL9643..
5/01/202316:00PRNUSPalatin Technologies to Host Key Opinion Leader Webinar
4/27/202307:30PRNUSPalatin Presents Initial Dry Eye Disease Phase 3 Clinical..
4/25/202307:30PRNUSPalatin Presents Data at the Association of Research in..
4/19/202307:30PRNUSPalatin Announces Preliminary Third Quarter Fiscal 2023..
4/18/202307:30PRNUSPre-Clinical Data of Palatin's Melanocortin Agonist..
3/02/202307:30PRNUSFrontiers in Immunology Publishes Pre-Clinical Study of..
2/28/202307:30PRNUSPalatin Issued Patent on Vyleesi® (Bremelanotide Injection)..
2/15/202307:30PRNUSPalatin Reports Second Quarter Fiscal Year 2023 Financial..
2/10/202307:30PRNUSPalatin to Report Second Quarter Fiscal Year 2023 Results;..
1/19/202307:30PRNUSPalatin Initiates Enrollment in the Phase 2 Bremelanotide..
1/18/202307:30PRNUSPalatin Receives $4.7 Million of Non-Dilutive Funding

Your Recent History

Delayed Upgrade Clock